GSID is currently working on the following major product development programs:

• A Path to an HIV Vaccine
• Thai Phase III HIV Vaccine Trial
• Dengue Vaccine Development

In addition to our major programs, GSID has recently been involved with monitoring Japanese Encephalitis (JE) immunization campaign, the development of flu manufacturing facilities in developing countries, and ongoing consultation for the WHO’s Global Polio Eradication initiative. Please contact us if you have any questions about these programs.

Previously, GSID conducted research on Global Public Health Surveillance Systems.

TIME honors our HIV vaccine as #2 Medical Breakthrough and #8 Innovation of the Year [more]